Language selection

Search

Details for: SANDOZ ESOMEPRAZOLE

Company: SANDOZ CANADA INCORPORATED

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02460920SANDOZ ESOMEPRAZOLEESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM DIHYDRATE)20 MGTABLET (DELAYED-RELEASE)ORAL
02460939SANDOZ ESOMEPRAZOLEESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM DIHYDRATE)40 MGTABLET (DELAYED-RELEASE)ORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - Proton Pump Inhibitors (PPIs) - Assessing the risk of a type of skin reaction [Subacute Cutaneous Lupus Erythematosus (SCLE)]

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: